Story
Jabil Tumbles While Google, FormFactor Gain in Mixed Trading

Summary
Shares of manufacturing services provider Jabil Inc. fell sharply on Wednesday, while tech giant Alphabet advanced. Semiconductor testing company FormFactor also rallied after receiving a new 'buy' rating from Deutsche Bank.
Shares of manufacturing services provider Jabil Inc. experienced a significant decline in Wednesday trading, while mega-cap technology firm Alphabet saw its stock advance. The semiconductor sector also saw notable activity, with FormFactor Inc. rallying after a positive analyst initiation.
Analyst Action Boosts FormFactor
FormFactor (FORM) was a standout gainer, with its shares climbing 7.93%. According to a report from Investing.com, the rally followed a new research note from Deutsche Bank, which initiated coverage on the stock with a "buy" rating.
The bank's positive outlook was reportedly based on a significant opportunity related to probe cards for Nvidia, a key component in the semiconductor testing process. An initiation with a buy rating often signals analyst confidence in a company's growth prospects.
Contrasting Fortunes for Large-Caps
AdIn contrast to FormFactor's gains, Jabil Inc. (JBL) was among the day's most significant decliners, with its stock falling 9.51%. Other large-cap stocks also faced downward pressure, including artificial intelligence firm Cerebras Systems (CBRS), which dropped 7.78%, and electronics manufacturer Sanmina-SCI Corp. (SANM), which fell 5.85%.
Meanwhile, Google parent Alphabet (GOOGL), a mega-cap stock with a market capitalization exceeding $200 billion, moved higher by 2.5%. The energy sector also saw a bright spot with GenOn Energy Inc. (GEN) rising 6.64%.
Mid-Cap Movers
Activity in the mid-cap space—stocks with a market capitalization between $2 billion and $10 billion—was also notable. Trulieve Cannabis (TRLV) experienced a particularly sharp sell-off, with its shares plummeting 16.84%.
Read next
More on Stocks
US Transportation Secretary Pushes to Expedite Aircraft Certification Amid China Competition Concerns
Transportation Secretary Sean Duffy stated the U.S. must speed up its aircraft approval process to maintain a competitive edge against China and encourage private investment in aviation innovation. The move follows existing FAA efforts to modernize certification.

Jefferies Identifies Three Biotech Firms with Blockbuster Drug Potential
Investment firm Jefferies has highlighted Delphia Therapeutics, Axsome Therapeutics, and BridgeBio Pharma as undervalued biotech companies with strong late-stage pipelines and significant commercial prospects.

Synopsys Shares Rise on OpenAI Partnership and Strong Revenue Forecast
Chip design software leader Synopsys is partnering with OpenAI on a revenue-sharing basis to develop a specialized AI model for semiconductor design, a move that boosted its stock and financial outlook.

Jefferies Initiates Coverage on Molbio Diagnostics with 'Buy' Rating
Jefferies has initiated coverage on Molbio Diagnostics, naming it a top pick in India's medical supplies sector with a 'Buy' rating and a price target of INR 1,600, citing the strength of its point-of-care diagnostics platform.